Table 4.

Logistic regression analysis for presence of CVD or presence of atherosclerotic plaque.

	Presence of CVD (n = 92)		Presence of atherosclerotic plaque (n = 92)
	OR (CI 95%)	P value	OR (CI 95%)	P value
Model 1
Age	1.04 (0.94–1.15)	0.47	1.01 (0.95–1.08)	0.72
Sex	0.44 (0.12–1.68)	0.23	0.70 (0.24–2.04)	0.52
Smoking	1.21 (0.23–6.26)	0.82	1.82 (0.56–5.88)	0.32
HT	0.96 (0.21–4.28)	0.95	0.76 (0.26–2.18)	0.60
DM	1.33 (0.35–5.02)	0.67	1.21 (0.50–2.95)	0.68
Model 2
Age	1.06 (0.95–1.18)	0.31	1.01 (0.95–1.08)	0.79
Sex	0.29 (0.05–1.51)	0.14	0.78 (0.26–2.39)	0.67
Smoking	2.42 (0.27–21.46)	0.43	1.78 (0.53–5.96)	0.35
HT	2.85 (0.46–17.54)	0.26	0.72 (0.24–2.11)	0.53
DM	0.78 (0.17–3.57)	0.75	1.40 (0.55–3.56)	0.48
PBCCs TNF/IL10	1.44 (0.98–2.11)	0.06	0.99 (0.93–1.06)	0.78
Serum TNFα/IL10	3.29 (0.52–20.89)	0.21	1.12 (0.95–1.32)	0.17
Model 3
Age	1.16 (0.96–1.40)	0.12	1.03 (0.96–1.11)	0.39
Sex	0.12 (0.01–1.30)	0.08	0.60 (0.18–2.03)	0.41
Smoking	5.06 (0.21–120.38)	0.32	2.01 (0.54–7.45)	0.30
HT	4.65 (0.42–51.31)	0.21	0.84 (0.24–2.93)	0.78
DM	0.36 (0.03–4.08)	0.41	1.14 (0.40–3.25)	0.80
PBCCs TNF/IL10	1.09 (0.79–1.51)	0.62	0.95 (0.88–1.02)	0.16
Serum TNFα/IL10	1.87 (0.33–10.63)	0.48	1.10 (0.93–1.31)	0.25
PBCCs KL	0.86 (0.75–0.97)	< 0.05	0.89 (0.81–0.99)	< 0.05
Serum sKL	0.99 (0.98–0.99)	< 0.05	0.99 (0.98–0.99)	< 0.05